Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys

Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs

(2010) Hsing-Ju Tsai et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure−Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain

(2010) Tristan E. Rose et al.   JOURNAL OF MEDICINAL CHEMISTRY

Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease

(2010) Oliver Jung et al.   PLoS One

Coronary heart disease of females: lessons learned from nonhuman primates

(2009) Thomas B. Clarkson et al.   AMERICAN JOURNAL OF PRIMATOLOGY

Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis)

(2009) Thomas C. Register   AMERICAN JOURNAL OF PRIMATOLOGY

Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

(2009) Jun Yang et al.   ANALYTICAL CHEMISTRY

Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia

(2009) Le-Ning Zhang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation

(2009) Jun-Yan Liu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

(2009) John D. Imig et al.   NATURE REVIEWS DRUG DISCOVERY

Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

(2008) Arzu Ulu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY